Triacsin C from Streptomyces sp. - 94%, high purity , CAS No.76896-80-5

  • ≥94%
Item Number
T139793
Grouped product items
SKUSizeAvailabilityPrice Qty
T139793-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$549.90
T139793-500μg
500μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,999.90
T139793-1mg
1mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$2,987.90
T139793-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$9,269.90

Potent, specific acyl-CoA synthetase inhibitor

View related series
Anti-infection Antibiotic Parasite

Basic Description

Synonyms2,4,7-Undecatrienal nitrosohydrazone | WS 1228A;FR 900190 | 1-Hydroxy-3-(2',4',7'-undecatrienylidine)triazene | 2,4,7-Undecatrienal, nitrosohydrazone, (E,E,E)- | (2E,4E,7E)-undecatrienal nitrosohydrazone | FR-900190 | (2E,4E,7E)-2,4,7-Undecatrienal nitros
Specifications & Purity≥94%
Biochemical and Physiological MechanismsTriacsin C is a potent inhibitor of long-chain fatty acyl CoA synthetase. It blocks β-cell apoptosis, induced by fatty acids (lipoapoptosis) in a rat model of obesity. In addition, it blocks the de novo synthesis of triglycerides, diglycerides, and choles
Storage TempProtected from light,Store at -20°C,Argon charged
Shipped InIce chest + Ice pads
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Triacsin C, an analog of polyunsaturated fatty acid. A potent vasodilator.
Selectively inhibits arachidonoyl-CoA synthetase in intact cells. Inhibits the nonspecific acyl-CoA synthetase in cell sonicates IC50=3.6-8.7 μM1–3. Inhibits neutrophil functions

Associated Targets(non-human)

Rotavirus (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name N-[(E)-[(2E,4E,7E)-undeca-2,4,7-trienylidene]amino]nitrous amide
INCHI InChI=1S/C11H17N3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15/h4-5,7-11H,2-3,6H2,1H3,(H,13,15)/b5-4+,8-7+,10-9+,12-11+
InChi Key NKTGCVUIESDXPU-YLEPRARLSA-N
Canonical SMILES CCCC=CCC=CC=CC=NNN=O
Isomeric SMILES CCC/C=C/C/C=C/C=C/C=N/NN=O
WGK Germany 3
PubChem CID 9576787
Molecular Weight 207.27

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

8 results found

Lot NumberCertificate TypeDateItem
J2421751Certificate of AnalysisOct 09, 2024 T139793
E2410340Certificate of AnalysisApr 11, 2024 T139793
K1908036Certificate of AnalysisSep 05, 2023 T139793
K2306130Certificate of AnalysisSep 05, 2023 T139793
H2329546Certificate of AnalysisAug 17, 2023 T139793
C2209138Certificate of AnalysisJan 19, 2022 T139793
C2209139Certificate of AnalysisJan 19, 2022 T139793
C2209140Certificate of AnalysisJan 19, 2022 T139793

Chemical and Physical Properties

SolubilitySoluble in DMSO (25 mg/ml), and methanol (5 mg/ml).
SensitivitySensitive to light; sensitive to humidity

Safety and Hazards(GHS)

WGK Germany 3

Related Documents

Citations of This Product

1. Huawei Xia, Zeming Zhang, Fuping You.  (2021)  Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection.  Viruses-Basel,  13  (12): (2383).  [PMID:34960652] [10.3390/v13122383]

References

1. Wong A et al..  (2018)  Lipid accumulation facilitates mitotic slippage-induced adaptation to anti-mitotic drug treatment..  Cell Death Discov,  (109).  [PMID:30510774]
2. Pinkosky SL et al..  (2016)  Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis..  Nat Commun,  (13457).  [PMID:27892461]
3. Huawei Xia, Zeming Zhang, Fuping You.  (2021)  Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection.  Viruses-Basel,  13  (12): (2383).  [PMID:34960652] [10.3390/v13122383]

Solution Calculators